Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07482501 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 25, 2026 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 15, 2026 to Sep 15, 2026
    • Study completion pushed from Sep 15, 2026 to Nov 15, 2026
    v4
  2. Recruitment opened
    • Start date changed from estimate of Mar 23, 2026 to Mar 26, 2026
    • Site details revised
    v3
  3. Primary endpoint revised
    • Interventions: Sham rTMS Protocol (Device), rTMS M1 Cortex Protocol (Device) to Sham rTMS Protocol (Device), rTMS M1 Motor Cortex Protocol (Device)
    • Secondary endpoints revised (6)
    • Eligibility criteria expanded, about 3 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) added to conventional neurological rehabilitation on heart rate variability (HRV), quality of life, upper extremity muscle strength and autonomic symptoms in patients with stroke.
Trial Details
NCT Number NCT07482501
Lead Sponsor Afyonkarahisar Health Sciences University
Conditions
(from sponsor)		 Stroke, Autonomic Dysfunction, Hemiparesis
Related terms Hemiplegia, Paresis, Primary Dysautonomias, Stroke
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov